Ambu A/S (CPH:AMBU.B)
65.70
+1.20 (1.86%)
At close: Apr 8, 2026
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 17.42 billion as of April 8, 2026. Its market cap has decreased by -46.89% in one year.
Market Cap
17.42B
Enterprise Value
17.24B
Revenue
6.09B
Ranking
n/a
PE Ratio
32.23
Stock Price
65.70
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 17.42B, an increase of 5,905.07%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 17.42B | -25.63% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.04T |
| Genmab | 107.53B |
| Coloplast | 95.74B |
| ALK-Abelló | 45.60B |
| Demant | 39.97B |
| H. Lundbeck | 38.09B |
| Zealand Pharma | 21.04B |
| Bavarian Nordic | 15.11B |